Clinical Trials Logo

Clinical Trial Summary

The objective of this research is the accumulation of gameplay data and simulator sickness background surveys for trend analysis, and individual simulator sickness trigger factor analysis for the test subjects involved. Rather than isolating specific variables for hypothesis formulation, this study will be attempting to collect an array of data that is a) both qualitative and quantitative, and b) observational and test subject-reported. The final results will consist of a list of possible trigger factors to avoid for individual subjects, and metrics showing the directional tendencies of players depending on the severity of their symptoms at the time. The overall goal of this research is to better understand factors that contribute to simulator sickness, both in who it affects and why some gameplay experiences may cause it more than others. Operating from the basic assumption that the way a player moves through an environment affects how quickly that player gets sick, we will primarily be gathering data on how the player moves through the digital space and whether that behavior changes once they begin to feel sick.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02122354
Study type Interventional
Source University of Southern California
Contact
Status Completed
Phase N/A
Start date April 2014
Completion date June 2014

See also
  Status Clinical Trial Phase
Recruiting NCT01198106 - A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness N/A